Spis treści
Gotowa bibliografia na temat „Scd6 C-terminal”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Scd6 C-terminal”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Scd6 C-terminal"
Chang, Eric, Geoffrey Bartholomeusz, Ruth Pimental, Jing Chen, Hong Lai, Li-hua L. Wang, Peirong Yang i Stevan Marcus. "Direct Binding and In Vivo Regulation of the Fission Yeast p21-Activated Kinase Shk1 by the SH3 Domain Protein Scd2". Molecular and Cellular Biology 19, nr 12 (1.12.1999): 8066–74. http://dx.doi.org/10.1128/mcb.19.12.8066.
Pełny tekst źródłaNelson, K. K., M. Holmer i S. K. Lemmon. "SCD5, a suppressor of clathrin deficiency, encodes a novel protein with a late secretory function in yeast." Molecular Biology of the Cell 7, nr 2 (luty 1996): 245–60. http://dx.doi.org/10.1091/mbc.7.2.245.
Pełny tekst źródłaChristiansen, Dale, Patricia Devaux, Brigitte Réveil, Alexey Evlashev, Branka Horvat, Josette Lamy, Chantal Rabourdin-Combe, Jacques H. M. Cohen i Denis Gerlier. "Octamerization Enables Soluble CD46 Receptor To Neutralize Measles Virus In Vitro and In Vivo". Journal of Virology 74, nr 10 (15.05.2000): 4672–78. http://dx.doi.org/10.1128/jvi.74.10.4672-4678.2000.
Pełny tekst źródłaZhao, Xiaoyang, Min Wang, Jingjing Liu i Xiong Su. "Stearoyl CoA Desaturase 1 and Inositol-Requiring Protein 1α Determine the Efficiency of Oleic Acid in Alleviating Silica Nanoparticle-Induced Insulin Resistance". Journal of Biomedical Nanotechnology 17, nr 7 (1.07.2021): 1349–63. http://dx.doi.org/10.1166/jbn.2021.3109.
Pełny tekst źródłaJha, Archana, Malini Ahuja, József Maléth, Claudia M. Moreno, Joseph P. Yuan, Min Seuk Kim i Shmuel Muallem. "The STIM1 CTID domain determines access of SARAF to SOAR to regulate Orai1 channel function". Journal of Cell Biology 202, nr 1 (1.07.2013): 71–79. http://dx.doi.org/10.1083/jcb.201301148.
Pełny tekst źródłaHenry, Kenneth R., Kathleen D'Hondt, JiSuk Chang, Thomas Newpher, Kristen Huang, R. Tod Hudson, Howard Riezman i Sandra K. Lemmon. "Scd5p and Clathrin Function Are Important for Cortical Actin Organization, Endocytosis, and Localization of Sla2p in Yeast". Molecular Biology of the Cell 13, nr 8 (sierpień 2002): 2607–25. http://dx.doi.org/10.1091/mbc.e02-01-0012.
Pełny tekst źródłaPapadaki, Piyi, Véronique Pizon, Brian Onken i Eric C. Chang. "Two Ras Pathways in Fission Yeast Are Differentially Regulated by Two Ras Guanine Nucleotide Exchange Factors". Molecular and Cellular Biology 22, nr 13 (1.07.2002): 4598–606. http://dx.doi.org/10.1128/mcb.22.13.4598-4606.2002.
Pełny tekst źródłaZhuang, Zhen-Jie, Chao-Wen Shan, Bo Li, Min-Xia Pang, Han Wang, Yan Luo, Yin-lan Liu i in. "Linarin Enriched Extract Attenuates Liver Injury and Inflammation Induced by High-Fat High-Cholesterol Diet in Rats". Evidence-Based Complementary and Alternative Medicine 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/4701570.
Pełny tekst źródłaYu, Wenjie, Cheng-Zhen Chen, Yanxia Peng, Ze Li, Yan Gao, Shuang Liang, Bao Yuan, Nam-Hyung Kim, Hao Jiang i Jia-Bao Zhang. "KRAS Affects Adipogenic Differentiation by Regulating Autophagy and MAPK Activation in 3T3-L1 and C2C12 Cells". International Journal of Molecular Sciences 22, nr 24 (20.12.2021): 13630. http://dx.doi.org/10.3390/ijms222413630.
Pełny tekst źródłaJung, Tae Woo, Sun-Young Kim, Da-Som Kim, Eui-Cheol Shin, Yong Bae Park i Kyoung-Tae Lee. "Euodia daniellii Hemsl. (Bee-Bee Tree) Oil Attenuates Palmitate-Induced Lipid Accumulation and Apoptosis in Hepatocytes". Pharmacology 101, nr 5-6 (2018): 298–308. http://dx.doi.org/10.1159/000487892.
Pełny tekst źródłaRozprawy doktorskie na temat "Scd6 C-terminal"
Tsou, Wei-Ling, i 鄒瑋玲. "Analyzing C-terminal alternative splicing of Cav2.1and developing the Splice-Isoform-Specific RNAi as apotential therapeutic strategy for SCA6". Thesis, 2011. http://ndltd.ncl.edu.tw/handle/67428207508990682896.
Pełny tekst źródła國立陽明大學
神經科學研究所
99
Spinocerebellar ataxia type 6 (SCA6) is an inherited neurodegenerative disorder characterized by the preferential degeneration of cerebellar Purkinje cells. SCA6 is caused by a polyglutamine (polyQ)-coding CAG repeat expansion in the 3’ end of the CACNA1A gene, which encodes the P/Q-type voltage-gated calcium channel alpha1A subunit Cav2.1. Purkinje cells express two major Cav2.1 mRNA splice isoforms (protein variants). The “long” variant (V2) contains the pathogenic polyglutamine expansion in the C-terminal tail, whereas the “short” variant (V1) lacks the polyglutamine tract. No effective treatments are currently available to combat this relentlessly progressive disorder; therefore, there is a pressing need to develop safe and efficacious therapies for preventing the neurodegeneration associated with SCA6. RNA interference is a promising therapeutic approach for neurodegenerative diseases, including various autosomal dominant spinocerebellar ataxias. Taking advantage of alternative splicing near the 3’ end of Cav2.1 transcripts, we designed splice isoform-specific (SIS)-RNAi molecules to selectively suppress expression of the polyQ-coding variant (V2). Embedding anti-SCA6 siRNAs within the context of a modified, brain-specific human miR-124 led to improved splice-specific target suppression compared to first generation shRNA platforms. We identified 3’ end base pair modifications in fully processed anti-SCA6 guide strands, supporting the proper recognition of these novel artificial miR124-based constructs by the cellular RNAi machinery. In the Cav2.1 mini-gene reporter system, CAG expansions were also found to enhance splicing activity at the 3’ end of Cav2.1, leading to a selective increase in the levels of polyQ-containing Cav2.1 variants, which may contribute to SCA6 disease pathogenesis. We cloned U6-miR124 expression cassettes into a recombinant adeno-associated viral (rAAV) vector for in vivo testing. Laser capture microdissection (LCM) of mouse Purkinje cells for Cav2.1 mRNA quantification revealed that the injection of mice with a low dose of rAAV-miR124 significantly reduced endogenous Cav2.1 expression. Unexpectedly, injection of high levels of rAAV induced significant neurotoxicity in mouse Purkinje neurons. Our results support the preclinical development of SIS-RNAi as a novel therapeutic approach for the treatment of SCA6; however, improper levels of rAAV-mediated delivery could be a potential concern. The long-term safety and efficacy of rAAV-mediated miRNA delivery should be further investigated in mouse models.